Focus: GE HealthCare is a diagnostic imaging and monitoring company with 940 active job openings, operating as a publicly-traded healthcare technology enterprise. They lead in contrast media, nuclear imaging agents, and diagnostic ultrasound/MRI platforms.
Profile data last refreshed 16h ago · AI intelligence enriched 2mo ago
Hot — 1268 jobs added in 30d
Net +565 (1268 new, 703 removed). Aggressive expansion phase.
Best fit for professionals seeking stable, large-company diagnostic innovation roles with strong engineering/manufacturing components; less ideal for those targeting cutting-edge therapeutic drug development.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Leading X-ray contrast agent facing imminent exclusivity loss; significant revenue vulnerability likely driving commercial strategy shifts.
Help build intelligence for GE HealthCare
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from GE HealthCare's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
A2A adenosine receptor agonist already post-loss of exclusivity; established utility in cardiac stress testing but facing generic competition.
Gadolinium contrast agent now generic; stable revenue base but limited growth prospects in mature MRI contrast market.
Iso-osmolar contrast medium with established safety profile; post-LOE but maintains steady demand in interventional cardiology.
46 discontinued, 14 duplicate formulations not shown
GE HealthCare Gains FDA Clearance for AI Radiation Planning Software - Yahoo Finance
GE HealthCare Gains FDA Clearance for AI Radiation Planning Software Yahoo Finance
GE HealthCare to Showcase Latest Technologies, AI-enabled Workflows - Imaging Technology News
GE HealthCare to Showcase Latest Technologies, AI-enabled Workflows Imaging Technology News
GE HealthCare’s AI-Driven Adaptive Theranostics Push Might Change The Case For Investing In GEHC - Sahm
GE HealthCare’s AI-Driven Adaptive Theranostics Push Might Change The Case For Investing In GEHC Sahm
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations - Business Wire
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations Business Wire
EQS-News: FAMAR Group announces contract manufacturing agreement with GE HealthCare - boerse.de - boerse.de
EQS-News: FAMAR Group announces contract manufacturing agreement with GE HealthCare - boerse.de boerse.de
Peter Arduini: Susquehanna Marketer, GE Healthcare Alumnus, and President and CEO of GE HealthCare - BBN Times
Peter Arduini: Susquehanna Marketer, GE Healthcare Alumnus, and President and CEO of GE HealthCare BBN Times
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo